XBIT
XBIT clinical trials: XBiotech Inc.
Every trial on ClinicalTrials.gov where XBiotech Inc. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 8
- Trials linked
- 8
- As lead sponsor
- 0
- As collaborator
- 1
- Primary completions as lead sponsor, next 90 days
XBIT on the catalyst calendar · XBIT registry changes
- Primary completion Oct 26, 2023ActualPhase 1/Phase 2NCT04825288XB2001 in Combination With ONIVYDE + 5-FU/LV (+Folinic Acid) in Advanced Pancreatic CancerXBiotech, Inc. · Pancreatic CancerCompletedXBITLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 8, 2022ActualPhase 1NCT05099510Safety and Pharmacokinetics (PK) Study of Natrunix in Healthy VolunteersXBiotech, Inc. · PharmacokineticsCompletedXBITLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 2028Sponsor estimatePhase 2NCT06526377Vilamakitug in Spondyloarthritis Placebo-controlled Investigation for EfficacyXBiotech, Inc. · Axial SpondyloarthritisNot yet recruitingXBITLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 2016ActualPhase 1/Phase 2NCT02357966Safety & Efficacy of True Human Antibody, 514G3, in Staphylococcus Aureus Bacteremia Hospitalized Subjects.XBiotech, Inc. · Staphylococcus Aureus BacteremiaCompletedXBITLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 15, 2027Sponsor estimatePhase 2NCT06590090Natrunix in Combination With Methotrexate for Rheumatoid Arthritis TreatmentXBiotech, Inc. · Rheumatoid ArthritisNot yet recruitingXBITLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 31, 2024ActualPhase 2NCT05363891Natrunix or Placebo in Combination With Methotrexate in Rheumatoid ArthritisXBiotech, Inc. · Rheumatoid ArthritisCompletedXBITLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 24, 2023ActualPhase 1NCT05098080Hutrukin to Analyze Safety and PK in Healthy VolunteersXBiotech, Inc. · PharmacokineticsCompletedXBITLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 15, 2022Sponsor estimatePhase 2NCT05363917Natrunix Versus Methotrexate in Rheumatoid ArthritisXBiotech, Inc. · Rheumatoid ArthritisUnknown statusXBITLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 8 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner